Skip to content
Search

Latest Stories

England dispensed 1.11 billion prescription items in 2020-21

The cost of prescription items dispensed in England in 2020-21 was £9.61 billion, a 3.49 per cent increase of £324 million from £9.28 billion in the previous year.

"This is the second consecutive year that the cost of items dispensed in England has increased following three consecutive years of decreases between 2015-16 and 2018-19," the NHS Business Services Authority (NHSBSA) said as it published its annual prescription cost analysis (PCA) today (June 10).


The number of prescription items dispensed was 1.11 billion, a 1.90 per cent decrease of 21.5 million items from 1.13 billion in 2019-20.

Atorvastatin, a 'statin' mainly used in lowering cholesterol in people suffering from high blood cholesterol or in prevention of heart disease, was found to be the most dispensed drug in England in 2020-21 with 49.9 million items.

Apixaban, an anticoagulant to prevent blood clots, was the drug with highest cost of £356 million.

Sertraline 100 mg (an antidepressant) tablet was the presentation with the "largest increase in cost between 2019-20 and 2020-21 of £78.9 million, from £21.0 million to £99.9 million."

As per the analysis, the cost of Sertraline increased by 376 per cent between 2019-20 and 2020-21, while the number of items prescribed increased by 7.51 per cent.

More For You

AAH Pharmaceuticals introduces 20 new electric vans to its delivery fleet

18 vans have been added to the AAH DC in Ruislip, and another 2 to their branch in Glasgow

Photo credit: AAH

AAH Pharmaceuticals adds 20 new electric vans to reduce carbon emissions

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced 20 new electric vans to its delivery fleet, marking a significant step forward in its Carbon Reduction Plan, which is aligned to the NHS net zero targets.

Eighteen of the new electric vehicles have been deployed at the AAH distribution centre in Ruislip, with the remaining two now in operation at its Glasgow branch.

Keep ReadingShow less
Numark launches new digital consultation platform to support independent prescribers

Harry McQuillan, Chairman of Numark

Numark launches DigiPharma to empower independent prescribers

Numark has launched a new digital consultation platform, called DigiPharma, designed to support both current and future independent prescribers (IPs) in making full use of their qualifications.

The revolutionary cloud-based prescribing recording platform is now available exclusively to Numark members.

Keep ReadingShow less
Operation Subaru:

Some of the medicines seized in raids today. Credit: MHRA

12 arrested in MHRA’s biggest medicines trafficking crackdown

Twelve people have been arrested in a series of dawn raids across the West Midlands and the Northwest of England today (29 April), as part of the biggest criminal investigation ever undertaken by the Medicines and Healthcare products Regulatory Agency (MHRA) into organised medicines trafficking.

The suspects were detained on suspicion of involvement in organised crime, conspiracy to sell or supply controlled and unlicensed medicines, and money laundering.

Keep ReadingShow less
Sukhi Basra named NPA vice-chair in historic leadership update with Olivier Picard as new chair

Olivier Picard steps up as NPA chair, Basra as vice-chair

Olivier Picard named new NPA chair

The National Pharmacy Association (NPA) has announced Olivier Picard as the organisation’s new chair.

Picard replaces Nick Kaye whose term comes to an end this week.

Keep ReadingShow less
 RPS honours Professor Tony Avery OBE for excellence in prescribing safety and patient care

Professor Tony Avery OBE

Pic credit: RPS

Professor Tony Avery OBE awarded RPS Honorary Fellowship

The Royal Pharmaceutical Society (RPS) Assembly has awarded an Honorary Fellowship to Professor Tony Avery OBE in recognition of his outstanding contribution to prescribing safety and patient care.

The Honorary Fellowship is given to those who are not eligible for membership of the Society but have either attained a distinction in a particular aspect or aspects of pharmacy, made a distinctive contribution to pharmacy or the RPS, distinguished themselves in any branches of knowledge referred to in the objects of the Society or achieved eminence in public life.

Keep ReadingShow less